SPRINGWORKS THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.53 USD | +3.01% |
|
+13.54% | +24.74% |
Chart calendar SpringWorks Therapeutics, Inc.
532a71581647bf.zcz7Kh-mE15fyL-Fr6h251K3t9Ue0bxcGn4yW7pwLvA.tf-STGvQXhwNgNHJ3OFDkjCPhoN15osbV0lBCvUkGMSgmbNAKZZLBz2cjw~72c5fa527fe0f49d5efe3dc0e83563ac
Upcoming events on SpringWorks Therapeutics, Inc.
Past events on SpringWorks Therapeutics, Inc.
| 12/03/2024 06:30 pm | Barclays Global Healthcare Conference |
| 05/03/2024 01:20 am | TD Cowen Health Care Conference |
| 27/02/2024 05:00 pm | Q4 2023 Earnings Release |
| 09/02/2024 12:30 am | Guggenheim Healthcare Talks Biotechnology Conference |
| 08/01/2024 09:00 pm | JPMorgan Healthcare Conference |
| 30/11/2023 07:15 pm | Evercore ISI HealthCONx Conference |
| 28/11/2023 06:30 pm | OGSIVEO Approval Call |
| 16/11/2023 07:00 pm | ReNeu Phase IIb Trial Topline Results Call |
| 02/11/2023 10:00 pm | Connective Tissue Oncology Society Meeting - Poster No: P 188 |
| 02/11/2023 04:00 pm | Q3 2023 Earnings Release |
| 02/08/2023 04:00 pm | Q2 2023 Earnings Release |
| 12/06/2023 11:50 pm | Goldman Sachs Global Healthcare Conference - Fireside Chat |
| 04/06/2023 03:00 am | American Society of Clinical Oncology Conference - Abstract No: 11514 |
| 03/06/2023 11:45 pm | American Society of Clinical Oncology Meeting - Abstract No: 11564 |
| 31/05/2023 10:30 pm | TD Cowen Oncology Innovation Summit |
| 24/05/2023 10:30 pm | Annual General Meeting |
| 09/05/2023 11:50 pm | Bank of America Healthcare Conference |
| 03/05/2023 04:00 pm | Q1 2023 Earnings Release |
| 18/04/2023 01:20 am | American Association for Cancer Research Meeting - Abstract Number #: CT033 |
| 18/04/2023 12:50 am | American Association for Cancer Research Meeting - Abstract No: CT031 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 35,0 21,0 66.67% | 0,00 0,00 - | 0,00 0,00 - | 5,45 1,01 439.77% | 87,8 |
|
EBITDA Million USD | Released Forecast Spread | -59,0 -60,0 1.64% | -46,0 -78,6 41.54% | -173 -151 -14.43% | -280 -275 -1.8% | -341 -334 -2.28% | -342 |
|
EBIT Million USD | Released Forecast Spread | -59,2 -59,2 -0.12% | -46,3 -59,4 22.01% | -173 -156 -11.27% | -281 -275 -1.95% | -343 -332 -3.41% | -336 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -58,3 -58,1 -0.28% | -45,6 -44,7 -2.01% | -174 -155 -12.54% | -277 -275 -1.02% | -325 -314 -3.56% | -311 |
|
Net income Million USD | Released Forecast Spread | -50,6 -58,2 13.06% | -45,6 -44,9 -1.58% | -174 -154 -13.22% | -277 -276 -0.54% | -325 -314 -3.41% | -329 |
|
EPS USD | Released Forecast Spread | -3,81 -2,33 -63.73% | -1,05 -1,36 23% | -3,59 -3,24 -10.8% | -5,21 -5,25 0.67% | -5,15 -4,92 -4.69% | -4,67 |
| Announcement Date | 12/03/20 | 25/02/21 | 24/02/22 | 28/02/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 5,45 0,90 502.99% | 13,1 | 21,5 | 27,1 | 37,0 | 45,7 |
|
EBITDA Million USD | Released Forecast Spread | -55,7 -42,0 -32.5% | -61,4 -57,0 -7.65% | -68,8 -64,0 -7.53% | -71,5 -73,0 2.02% | -78,2 -76,0 -2.89% | -77,4 -84,0 7.8% | -82,5 -79,0 -4.39% | |||||||
|
EBIT Million USD | Released Forecast Spread | -55,8 -41,9 -33.18% | -61,5 -57,7 -6.58% | -69,0 -63,8 -8.24% | -71,7 -70,5 -1.71% | -78,5 -73,0 -7.45% | -77,7 -78,9 1.53% | -82,9 -80,0 -3.63% | -84,0 -86,1 2.49% | -98,5 -88,2 -11.68% | -88,7 | -83,6 | -78,5 | -76,0 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -56,1 -41,4 -35.51% | -61,8 -57,0 -8.45% | -69,1 -63,3 -9.03% | -72,4 -70,6 -2.6% | -74,2 -72,9 -1.72% | -73,4 -77,7 5.49% | -77,9 -77,9 -0.09% | -79,4 -84,0 5.39% | -94,3 -83,3 -13.19% | -83,9 | -81,4 | -77,7 | -72,6 | |
|
Net income Million USD | Released Forecast Spread | -56,1 -41,4 -35.51% | -61,8 -57,0 -8.45% | -69,1 -63,3 -9.03% | -72,4 -70,6 -2.6% | -74,2 -72,9 -1.82% | -73,4 -77,7 5.49% | -77,9 -77,9 -0.09% | -79,4 -84,0 5.39% | -94,3 -83,3 -13.19% | -83,9 | -81,4 | -77,7 | -72,6 | |
|
EPS USD | Released Forecast Spread | -1,16 -0,88 -32.12% | -1,26 -1,05 -19.93% | -1,41 -1,26 -12.26% | -1,37 -1,32 -3.99% | -1,17 -1,22 4.24% | -1,18 -1,25 5.83% | -1,25 -1,26 0.89% | -1,27 -1,33 4.54% | -1,45 -1,24 -17.2% | -1,18 | -1,15 | -1,10 | -1,07 | -1,16 |
| Announcement Date | 24/02/22 | 05/05/22 | 04/08/22 | 03/11/22 | 28/02/23 | 03/05/23 | 02/08/23 | 02/11/23 | 27/02/24 | - | - | - | - | - |
More events
Past sector events for SpringWorks Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SWTX Stock
- Calendar SpringWorks Therapeutics, Inc.
